{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:07:35Z","timestamp":1774580855820,"version":"3.50.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Renal function is one of the crucial components for determining the dose and type of oral anticoagulants in atrial fibrillation (AF) patients, and is also closely associated with the risks of stroke and bleeding. This study aimed to assess renal function changes and their impact on clinical outcomes in anticoagulated AF patients with marginal renal function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From a Korean claims database, patients with AF on anticoagulants and a baseline eGFR of 45 to &amp;lt;60\u2005ml\/min\/1.73\u2005m<jats:sup>2<\/jats:sup> were studied. Patients were grouped by changes in renal function over two years\u2014maintained, improved (eGFR &amp;gt;60\u2005ml\/min\/1.73\u2005m<jats:sup>2<\/jats:sup>), or worsened (eGFR &amp;lt;45\u2005ml\/min\/1.73\u2005m<jats:sup>2<\/jats:sup>)\u2014the study analyzed outcomes including ischemic stroke, major bleeding, end-stage renal disease (ESRD), all-cause death, and a composite of clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 5,126 patients were included in the study: 2,170 (42.3%) in the maintained group, 2,276 (44.4%) in the improved group, and 680 (13.1%) in the group with worsened renal function. The worsened group was older and had more prevalent comorbidities than other groups. After multivariable adjustment, the worsened group was associated with significantly higher risks of major bleeding (adjusted hazard ratio, 95% confidence interval; 1.46, 1.03\u20132.07, <jats:italic>p<\/jats:italic>\u2009=\u20090.035), ESRD (1.49, 1.24\u20131.80, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), all-cause death (9.29, 4.92\u201317.6, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), and the composite outcome (1.57, 1.36\u20131.83, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In anticoagulated AF patients with marginal renal function, a substantial proportion of patients experienced renal function decline below eGFR 45\u2005ml\/min\/1.73\u2005m<jats:sup>2<\/jats:sup> within 2 years. Renal function decline was associated with higher risks of major bleeding, ESRD, all-cause death, and the composite outcome compared to those who maintained their baseline renal function.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1423336","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:29:57Z","timestamp":1718134197000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between changes in renal function and clinical outcomes in anticoagulated atrial fibrillation patients with marginal renal function. A nationwide observational cohort study"],"prefix":"10.3389","volume":"11","author":[{"given":"Kyung-Yeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-Ryoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JungMin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Jeong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soonil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1007\/s12325-023-02544-8","article-title":"Prescription of DOACs in patients with atrial fibrillation at different stages of renal insufficiency","volume":"40","author":"Hahn","year":"2023","journal-title":"Adv Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"30271","DOI":"10.1038\/srep30271","article-title":"Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes","volume":"6","author":"Boriani","year":"2016","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 Focused update consensus guidelines of the Asia pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10157-017-1453-2","article-title":"A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: the reach-J CKD cohort study","volume":"22","author":"Hoshino","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad271","article-title":"Risk factor analysis for a rapid progression of chronic kidney disease","author":"Vestergaard","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"EP Europace"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/j.jacc.2017.03.600","article-title":"Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction","volume":"69","author":"Yao","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e014177","DOI":"10.1161\/JAHA.119.014177","article-title":"Label adherence of direct oral anticoagulants dosing and clinical outcomes in patients with atrial fibrillation","volume":"9","author":"Yu","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.hrthm.2020.07.022","article-title":"Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation","volume":"17","author":"Chan","year":"2020","journal-title":"Heart Rhythm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","article-title":"Data resource profile: the national health information database of the national health insurance service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","article-title":"Cardiovascular research using the Korean national health information database","volume":"50","author":"Choi","year":"2020","journal-title":"Korean Circ J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic kidney disease and prevalent atrial fibrillation: the chronic renal insufficiency cohort (CRIC)","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e028496","DOI":"10.1161\/JAHA.122.028496","article-title":"Association of chronic kidney disease with atrial fibrillation in the general adult population: a nationwide population-based study","volume":"12","author":"Kim","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/europace\/euv202","article-title":"Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European heart rhythm association endorsed by the heart rhythm society and the Asia pacific heart rhythm society","volume":"17","author":"Boriani","year":"2015","journal-title":"Europace"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1055\/s-0042-1756355","article-title":"Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry phase II and III","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e167517","DOI":"10.1172\/JCI167517","article-title":"Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation","volume":"133","author":"Song","year":"2023","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.23876\/j.krcp.2018.37.2.103","article-title":"Atrial fibrillation and chronic kidney disease: a bad combination","volume":"37","author":"Kiuchi","year":"2018","journal-title":"Kidney Res Clin Pract"},{"key":"B22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4065\/76.5.467","article-title":"Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women","volume":"76","author":"Tsang","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"c4249","DOI":"10.1136\/bmj.c4249","article-title":"Low glomerular filtration rate and risk of stroke: meta-analysis","volume":"341","author":"Lee","year":"2010","journal-title":"Br Med J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.kint.2016.10.017","article-title":"The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation","volume":"91","author":"Keskar","year":"2017","journal-title":"Kidney Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"k342","DOI":"10.1136\/bmj.k342","article-title":"Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care","volume":"360","author":"Kumar","year":"2018","journal-title":"Br Med J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.jacc.2019.08.1031","article-title":"Anticoagulation in concomitant chronic kidney disease and atrial fibrillation","volume":"74","author":"Kumar","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/heartjnl-2019-315792","article-title":"Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation","volume":"106","author":"Inohara","year":"2020","journal-title":"Heart"},{"key":"B28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3349\/ymj.2019.60.3.277","article-title":"Label adherence for non-vitamin K antagonist oral anticoagulants in a prospective cohort of Asian patients with atrial fibrillation","volume":"60","author":"Lee","year":"2019","journal-title":"Yonsei Med J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2125.1981.tb01848.x","article-title":"Glomerular filtration rate and creatinine clearance","volume":"12","author":"Kampmann","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cjca.2018.04.019","article-title":"Variability in non-vitamin K antagonist oral anticoagulants dose adjustment in atrial fibrillation patients with renal dysfunction: the influence of renal function estimation formulae","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","article-title":"Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.amjmed.2016.08.019","article-title":"Creatinine clearance is not equal to glomerular filtration rate and cockcroft-gault equation is not equal to CKD-EPI collaboration equation","volume":"129","author":"Fernandez-Prado","year":"2016","journal-title":"Am J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jacasi.2023.02.002","article-title":"Renal function and clinical outcomes among elderly patients with nonvalvular atrial fibrillation from ANAFIE","volume":"3","author":"Shimizu","year":"2023","journal-title":"JACC Asia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1001\/jama.2011.659","article-title":"Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation","volume":"305","author":"Conen","year":"2011","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1536\/ihj.19-205","article-title":"Factors associated with a large decline in renal function or progression to renal insufficiency in hospitalized atrial fibrillation patients with early-stage CKD","volume":"61","author":"Hu","year":"2020","journal-title":"Int Heart J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ahj.2016.08.017","article-title":"Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants","volume":"184","author":"Fanola","year":"2017","journal-title":"Am Heart J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijcard.2017.10.110","article-title":"The CHA(2)DS(2)-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease","volume":"253","author":"Beyer-Westendorf","year":"2018","journal-title":"Int J Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/kisup.2012.77","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Eknoyan","year":"2013","journal-title":"Kidney int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10157-023-02389-z","article-title":"Kidney function monitoring and trajectories in patients with atrial fibrillation","volume":"27","author":"Hawkins","year":"2023","journal-title":"Clin Exp Nephrol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1055\/a-1467-2993","article-title":"Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms","volume":"122","author":"Lip","year":"2022","journal-title":"Thromb Haemost"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1770724","article-title":"Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis","author":"Zheng","year":"2023","journal-title":"Thromb Haemost"},{"key":"B45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0043-1772773","article-title":"Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF registry","volume":"124","author":"Treewaree","year":"2024","journal-title":"Thromb Haemost"},{"key":"B46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The east Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"Kim","year":"2021","journal-title":"Thromb Haemost"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-pacific expert consensus paper","volume":"122","author":"Gorog","year":"2022","journal-title":"Thromb Haemost"},{"key":"B48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018atrial fibrillation better care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-A systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e019609","DOI":"10.1161\/JAHA.120.019609","article-title":"Non-Vitamin K antagonist oral anticoagulants provide less adverse renal outcomes than warfarin in non-valvular atrial fibrillation: a systematic review and metaanalysis","volume":"10","author":"Sitticharoenchai","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B50","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jjcc.2020.07.002","article-title":"Improvement in renal and endothelial function after catheter ablation in patients with persistent atrial fibrillation","volume":"76","author":"Okawa","year":"2020","journal-title":"J Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1423336\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:29:59Z","timestamp":1718134199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1423336\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":50,"alternative-id":["10.3389\/fcvm.2024.1423336"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1423336","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"article-number":"1423336"}}